Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy
WARNING LETTER
•Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy•December 13, 2019

Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy – FDA Warning Letter, Dec 13, 2019

Record Details

On February 1, 2021, the FDA issued a Warning Letter to Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy following an inspection from December 2-13, 2019. The inspection revealed serious deficiencies in sterile drug product production, leading to adulterated drug products under FDCA Section 501(a)(2)(A).

Key violations include: 1. Failure to remediate repeated microbial contamination in ISO 7 cleanrooms, ISO 5 biological safety cabinet (BSC), and ISO 5 laminar air flow (LAF) hood, and failure to evaluate its impact on aseptically processed drugs. 2. Deficient facility design, including issues with cleanroom air filtration (unclamped, failed leak test HEPA filter), ceiling air returns, simultaneous opening of doors between classified and unclassified areas, inability to maintain differential pressure, and dust accumulation on air supply vents. 3. Failure to perform adequate smoke studies under dynamic conditions for the ISO 5 BSC. 4. Use of a non-sterile disinfectant in the ISO 5 aseptic processing area.

The FDA reviewed the firm's January 3, 2020, response but found it lacked sufficient information or supporting documentation for proposed corrective actions, such as finalized design changes, evidence of purchased equipment, proof of sterile cleaning agent use, additional environmental monitoring data, and evaluation of sporicidal agent frequency. The FDA strongly

Company
Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy
Inspection date
December 13, 2019
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations IV
Person
  • Steven E. Porter (Program Division Director)
View Company Profile

ID · 5d708eb5-b6a1-4525-9c66-599b735e37a9

Violation Codes9
FD&C Act 501(a)(2)(B)FD&C Act 502(f)(1)FD&C Act 505FD&C Act 503AFD&C Act 501(a)(2)(A)21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 331(k)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy
  • 483 - 2019-12-13December 13, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.